Cargando…
Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance
Invasive non-typhoidal Salmonella (NTS) is among the leading causes of blood stream infections in sub-Saharan Africa and other developing regions, especially among pediatric populations. Invasive NTS can be difficult to treat and have high case-fatality rates, in part due to emergence of strains res...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677775/ https://www.ncbi.nlm.nih.gov/pubmed/31375759 http://dx.doi.org/10.1038/s41598-019-47359-2 |
_version_ | 1783440953387778048 |
---|---|
author | Manore, Carrie Graham, Todd Carr, Alexa Feryn, Alicia Jakhar, Shailja Mukundan, Harshini Highlander, Hannah Callender |
author_facet | Manore, Carrie Graham, Todd Carr, Alexa Feryn, Alicia Jakhar, Shailja Mukundan, Harshini Highlander, Hannah Callender |
author_sort | Manore, Carrie |
collection | PubMed |
description | Invasive non-typhoidal Salmonella (NTS) is among the leading causes of blood stream infections in sub-Saharan Africa and other developing regions, especially among pediatric populations. Invasive NTS can be difficult to treat and have high case-fatality rates, in part due to emergence of strains resistant to broad-spectrum antibiotics. Furthermore, improper treatment contributes to increased antibiotic resistance and death. Point of care (POC) diagnostic tests that rapidly identify invasive NTS infection, and differentiate between resistant and non-resistant strains, may greatly improve patient outcomes and decrease resistance at the community level. Here we present for the first time a model for NTS dynamics in high risk populations that can analyze the potential advantages and disadvantages of four strategies involving POC diagnostic deployment, and the resulting impact on antimicrobial treatment for patients. Our analysis strongly supports the use of POC diagnostics coupled with targeted antibiotic use for patients upon arrival in the clinic for optimal patient and public health outcomes. We show that even the use of imperfect POC diagnostics can significantly reduce total costs and number of deaths, provided that the diagnostic gives results quickly enough that patients are likely to return or stay to receive targeted treatment. |
format | Online Article Text |
id | pubmed-6677775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-66777752019-08-08 Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance Manore, Carrie Graham, Todd Carr, Alexa Feryn, Alicia Jakhar, Shailja Mukundan, Harshini Highlander, Hannah Callender Sci Rep Article Invasive non-typhoidal Salmonella (NTS) is among the leading causes of blood stream infections in sub-Saharan Africa and other developing regions, especially among pediatric populations. Invasive NTS can be difficult to treat and have high case-fatality rates, in part due to emergence of strains resistant to broad-spectrum antibiotics. Furthermore, improper treatment contributes to increased antibiotic resistance and death. Point of care (POC) diagnostic tests that rapidly identify invasive NTS infection, and differentiate between resistant and non-resistant strains, may greatly improve patient outcomes and decrease resistance at the community level. Here we present for the first time a model for NTS dynamics in high risk populations that can analyze the potential advantages and disadvantages of four strategies involving POC diagnostic deployment, and the resulting impact on antimicrobial treatment for patients. Our analysis strongly supports the use of POC diagnostics coupled with targeted antibiotic use for patients upon arrival in the clinic for optimal patient and public health outcomes. We show that even the use of imperfect POC diagnostics can significantly reduce total costs and number of deaths, provided that the diagnostic gives results quickly enough that patients are likely to return or stay to receive targeted treatment. Nature Publishing Group UK 2019-08-02 /pmc/articles/PMC6677775/ /pubmed/31375759 http://dx.doi.org/10.1038/s41598-019-47359-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Manore, Carrie Graham, Todd Carr, Alexa Feryn, Alicia Jakhar, Shailja Mukundan, Harshini Highlander, Hannah Callender Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance |
title | Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance |
title_full | Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance |
title_fullStr | Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance |
title_full_unstemmed | Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance |
title_short | Modeling and Cost Benefit Analysis to Guide Deployment of POC Diagnostics for Non-typhoidal Salmonella Infections with Antimicrobial Resistance |
title_sort | modeling and cost benefit analysis to guide deployment of poc diagnostics for non-typhoidal salmonella infections with antimicrobial resistance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677775/ https://www.ncbi.nlm.nih.gov/pubmed/31375759 http://dx.doi.org/10.1038/s41598-019-47359-2 |
work_keys_str_mv | AT manorecarrie modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance AT grahamtodd modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance AT carralexa modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance AT ferynalicia modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance AT jakharshailja modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance AT mukundanharshini modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance AT highlanderhannahcallender modelingandcostbenefitanalysistoguidedeploymentofpocdiagnosticsfornontyphoidalsalmonellainfectionswithantimicrobialresistance |